Cognitive Disorders Clinical Trial
Official title:
An Open Label Positron Emission Tomography (PET) Study to Investigate Brain Penetration by [Carbonyl-11C] GSK1034702 in Healthy Subjects
GSK1034702 is being developed for improving cognitive impairment in diseases such as Alzheimer's disease and schizophrenia. This study will be done in healthy men to investigate how much of the study drug gets into the brain. This will be done using Positron Emission Tomography (PET).
This is an open label, single dose, non-randomized PET study in healthy male subjects to ascertain if GSK1034702 is crossing the blood-brain barrier to enable it to elicit a central effect. GSK1034702 has been shown in vitro to be a substrate for human Pgp, therefore the distribution of GSK1034702 into human brain could be adversely affected. This use of PET in conjunction with radioactively labelled GSK1034702 will help ascertain the role Pgp plays in limiting brain penetration in the presence and absence of a pharmacological relevant oral non labelled dose of 5 mg. Subjects will have an MRI scan to aid definition of brain anatomy, a baseline PET scan and a post-dose PET scan. For each subject the study will consist of at least three visits; screening visit, scanning day and follow-up. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
| Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
| Completed |
NCT02342041 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT01659593 -
Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT01561820 -
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
|
N/A | |
| Completed |
NCT00743405 -
Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05373394 -
Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
|
||
| Completed |
NCT04860414 -
Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.
|
N/A | |
| Completed |
NCT02324153 -
Ramelteon in the Prevention of Post-operative Delirium
|
Phase 2 | |
| Completed |
NCT00458094 -
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
|
N/A | |
| Completed |
NCT05486195 -
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
|
Phase 1 | |
| Not yet recruiting |
NCT03866018 -
Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders
|
N/A | |
| Recruiting |
NCT02876536 -
Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT02321475 -
EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
|
||
| Completed |
NCT01881646 -
Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery
|
Phase 4 | |
| Recruiting |
NCT05888961 -
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
|
N/A | |
| Completed |
NCT01983384 -
Anesthetic Depth and Postoperative Delirium Trial - 2
|
N/A | |
| Completed |
NCT02575482 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01772095 -
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
|
N/A | |
| Completed |
NCT06078332 -
Remote Cognitive Multidomain Assessment in People With Cognitive Disorders
|